Diabetes

High blood sugar levels and BMI linked to stillbirth in mothers with diabetes

2019-08-06T10:04:47+01:00

High maternal blood sugar levels and BMI are risk factors for stillbirth in mothers with diabetes, according to a new study in Diabetologia (the journal of the European Association for the Study of Diabetes), with babies at the lowest and highest weights being most at risk.

High blood sugar levels and BMI linked to stillbirth in mothers with diabetes2019-08-06T10:04:47+01:00

UK study shows obesity in pregnant women associated with a 3.5 times increased risk of type 2 diabetes in the child

2019-07-25T14:08:04+01:00

Obesity during pregnancy is associated with a 3.5-times increased future risk of type 2 diabetes (T2D) in the child, concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes).

UK study shows obesity in pregnant women associated with a 3.5 times increased risk of type 2 diabetes in the child2019-07-25T14:08:04+01:00

Domestic refrigerators may pose risk to insulin quality

2019-06-05T16:00:35+01:00

New research being presented at this year’s European Association for the Study of Diabetes (EASD) Annual Meeting in Berlin, Germany (1–5 October), suggests that insulin is often stored at the wrong temperature in patients’ fridges at home, which could affect its potency.

Domestic refrigerators may pose risk to insulin quality2019-06-05T16:00:35+01:00

Study finds people with type 2 diabetes at higher risk of death from both obesity-related and non-obesity related cancers

2019-06-05T16:00:35+01:00

Being overweight or obese may put adults with diabetes at greater risk of dying from cancer than their diabetes-free counterparts, particularly for obesity-related cancers such as those arising from the bowel, kidney, and pancreas in men and women, and from the breast and endometrium (lining of the uterus) in women.

Study finds people with type 2 diabetes at higher risk of death from both obesity-related and non-obesity related cancers2019-06-05T16:00:35+01:00

On current trends, almost a quarter of people in the world will be obese by 2045, and one in eight will have type 2 diabetes

2019-06-05T16:00:35+01:00

New research from various cities in the world presented at this year's European Congress on Obesity in Vienna, Austria (23-26 May) demonstrate that if current trends continue, almost a quarter (22%) of the people in the world will be obese by 2045 (up from 14% in 2017), and one in eight (12%) will have type 2 diabetes (up from 9% in 2017).

On current trends, almost a quarter of people in the world will be obese by 2045, and one in eight will have type 2 diabetes2019-06-05T16:00:35+01:00

Younger age at diabetes diagnosis is linked to higher risk of death from heart disease and stroke, yet lower risk of cancer death

2019-06-05T16:00:35+01:00

While type 2 diabetes (T2D) was once considered a disease largely confined to older people, the global epidemic of obesity and overweight has seen diagnoses rocket in young adults, adolescents and even appear in young children.

Younger age at diabetes diagnosis is linked to higher risk of death from heart disease and stroke, yet lower risk of cancer death2019-06-05T16:00:35+01:00

Study shows that the consumption of antioxidant-rich foods is associated with a lower risk of type 2 diabetes

2019-06-05T16:00:36+01:00

A lower risk of type 2 diabetes has been observed among individuals consuming food rich in antioxidants. This effect is largely contributed by fruit, vegetables, tea and other hot beverages, as well as moderate consumption of alcohol, as shown in a recent study from an Inserm research group, published in Diabetologia, the journal of the European Association for the Study of Diabetes (EASD)

Study shows that the consumption of antioxidant-rich foods is associated with a lower risk of type 2 diabetes2019-06-05T16:00:36+01:00

New device that tackles obesity and diabetes shows promise as NHS treatment

2019-06-05T16:00:36+01:00

The UK's first National Health Service (NHS) service to provide a new, non-surgical, reversible weight loss device for people who have both poorly controlled type 2 diabetes and obesity is safe and effective and should be rolled out across the NHS, according to new research being presented at this year's European Association for the Study of Diabetes (EASD) Annual Meeting in Lisbon, Portugal (11-15 September).

New device that tackles obesity and diabetes shows promise as NHS treatment2019-06-05T16:00:36+01:00
Load More Posts